Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG CLASS:
CD133-targeted CAR-T immunotherapy
DRUG CLASS:
CD133-targeted CAR-T immunotherapy
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related drugs:
‹
CD133-specific CAR-T cell therapy (2)
Tris-CAR-T cell therapy (0)
CD133-specific CAR-T cell therapy (2)
Tris-CAR-T cell therapy (0)
›
Associations
(2)
News
Trials
VERI cancer hierarchy
Reset Filters
CD133 positive
Glioblastoma
CD133 positive
Glioblastoma
CD133-specific CAR-T cell therapy
Sensitive: D – Preclinical
CD133-specific CAR-T cell therapy
Sensitive
:
D
CD133-specific CAR-T cell therapy
Sensitive: D – Preclinical
CD133-specific CAR-T cell therapy
Sensitive
:
D
CD133 expression
Colon Cancer
CD133 expression
Colon Cancer
CD133-specific CAR-T cell therapy + STAT-600
Sensitive: D – Preclinical
CD133-specific CAR-T cell therapy + STAT-600
Sensitive
:
D
CD133-specific CAR-T cell therapy + STAT-600
Sensitive: D – Preclinical
CD133-specific CAR-T cell therapy + STAT-600
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login